1. Home
  2. SRI vs ACIU Comparison

SRI vs ACIU Comparison

Compare SRI & ACIU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Stoneridge Inc.

SRI

Stoneridge Inc.

HOLD

Current Price

$5.94

Market Cap

172.9M

ML Signal

HOLD

Logo AC Immune SA

ACIU

AC Immune SA

HOLD

Current Price

$3.14

Market Cap

213.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SRI
ACIU
Founded
1965
2003
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
172.9M
213.3M
IPO Year
1997
2016

Fundamental Metrics

Financial Performance
Metric
SRI
ACIU
Price
$5.94
$3.14
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$16.00
$10.00
AVG Volume (30 Days)
140.2K
1.2M
Earning Date
11-05-2025
11-04-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$874,357,000.00
$5,482,957.00
Revenue This Year
N/A
N/A
Revenue Next Year
$7.68
$738.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.54
$1.43
52 Week High
$9.10
$4.00

Technical Indicators

Market Signals
Indicator
SRI
ACIU
Relative Strength Index (RSI) 48.26 55.61
Support Level $5.54 $2.54
Resistance Level $6.35 $2.99
Average True Range (ATR) 0.22 0.29
MACD 0.10 0.03
Stochastic Oscillator 55.17 50.40

Price Performance

Historical Comparison
SRI
ACIU

About SRI Stoneridge Inc.

Stoneridge Inc is a manufacturer of electrical and electronic components used in automotive vehicles. The company produces instrumentation systems, vehicle management electronics, application-specific switches and actuators, sensors, security alarms, and vehicle tracking devices and monitoring services for commercial, automotive, off-highway, and agricultural vehicle markets. The company has three reportable segments: Control Devices, Electronics, and Stoneridge Brazil. It generates the majority of its revenue from the Electronics segment that produces driver information systems, camera-based vision systems, connectivity, and compliance products, and electronic control units. Its geographic segments include America, South America, Europe and Other.

About ACIU AC Immune SA

AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses mostly of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.

Share on Social Networks: